Gero-LLM: A Multimodal Large Language Model for Geroprotector Discovery via Cross-Modal Differentiated Mutual Learning.
Abstract
Geroprotectors underpin therapeutic strategies to intervene in aging pathologies and extend lifespans. Unfortunately, geroprotector discovery remains a significant challenge due to data quality and pathway redundancy. Existing methods often rely on single data modalities, which fail in capturing the intricate structure-activity relationships in geroprotector molecules. Therefore, we present Gero-LLM, a multimodal framework that synergizes the reasoning capabilities of pre-trained large language models (LLMs) with the topological modeling of Graph Isomorphism Network with Edge features (GINE) for geroprotector discovery. By fusing textual representations with structural embeddings, Gero-LLM leverages multimodal chemical information to enhance predictive ability. To overcome the limitations of standard fine-tuning, we utilize a cross-modal differentiated deep mutual learning (CM-Diff-DML) strategy. This training paradigm enforces the diversity between modalities, preventing mode collapse and improving model prediction ability. Gero-LLM achieves state-of-the-art performance, demonstrating promising robustness on highly imbalanced external datasets, resembling the real-world geroprotector screening scenarios. Furthermore, in silico mutagenesis confirms that Gero-LLM captures fundamental chemical pharmacophores beyond summary statistics. This work attempts to bridge the gaps between LLMs and multimodal molecule information, providing a robust platform to accelerate the discovery of therapeutic interventions on aging.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
Gero-LLM proposes a multimodal framework for discovering geroprotectors that can potentially intervene in aging processes. The paper is relevant as it addresses the discovery of therapeutic interventions aimed at the root causes of aging rather than merely treating age-related symptoms.
Author of this paper? Send a correction.